Insiders who reported open-market trades in the last 12 months at the companies Patrick Harrison Carroll files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Andrew Dudum - $11.03M in HIMS purchases and sales in the last 12 months
Oluyemi Okupe - $9.22M in HIMS purchases and sales in the last 12 months
Michael Chi - $3.24M in HIMS purchases and sales in the last 12 months
Soleil Boughton - $1.87M in HIMS purchases and sales in the last 12 months
David B. Wells - $1.17M in HIMS purchases and sales in the last 12 months
Mohamed Elshenawy - $1.17M in HIMS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Patrick Harrison Carroll is a corporate insider, tracked as Chief Medical Officer of Hims & Hers Health, Inc. (HIMS). InsiderAlpha holds 15 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Patrick Harrison Carroll submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Patrick Harrison Carroll been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($5.02M) across all tracked filings.
Patrick Harrison Carroll is Chief Medical Officer of Hims & Hers Health, Inc. (HIMS). 15 SEC Form 4 filings on record going back to 2024, most recently on 18 August 2026. Most recent open-market trade: sold $830K of HIMS on 23 June 2026. Lifetime open-market sales: $5.02M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Patrick Harrison Carroll.
InsiderAlpha's records for Patrick Harrison Carroll go back to 2024: 15 primary Form 4 filings, an average of 5.0 per year. 1 recorded transaction carries a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
